Investing
1488 Articles
September 26, 2016: Markets opened lower again Monday and only the recently added real-estate sector traded higher on the day.…
Pfizer shares traded down marginally Monday morning after the company announced that it will abandon its plan to split into…
While the polls have the race pretty tight, one thing is for sure: a victory by Donald Trump would favor…
The volatility in the markets have shaken some of the top dividend leaders and may be giving long-term investors a…
Despite recent market headwinds and volatility, there are strong underlying fundamentals among the large cap pharmaceuticals that are continuing to…
The August 31 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…
In a new research report, Baird notes two biotech companies in its research coverage universe that may be considered speculative…
The August 15 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…
In one of the longest running bidding wars in recent times, Pfizer has finally reeled in cancer-drug maker Medivation.
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have…
August 17, 2016: Markets opened slightly lower Wednesday following a slide in European markets. Utility stocks were the leading sector…
Credit Suisse has run bullish and bearish scenarios for what the firm feels is a reasonable upside and downside for…
In the latest Merrill Lynch RIC Report, which is effectively a culmination of the firm's top research ideas, views and…
The Dow Jones Industrial Average hit yet another all-time high on Thursday, August 11, 2016. What is amazing is that…
The July 29 short interest data have been compared with the previous figures, and for most of the selected pharmaceutical…
Our top personal finance-related articles today. Your wallet will thank you later.